TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to ...

Pharmaceutical company Moderna has been granted the funds to work on developing mRNA-based influenza vaccines, including for the strain causing the bird flu outbreak. Newsweek has contacted ...

↘️ MicroStrategy (MSTR): Cryptocurrencies pulled back after President Trump didn't mention crypto in his inauguration address. Shares in MicroStrategy, which also disclosed it had recently ...

The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well as work on mRNA vaccines for other influenza strains with pandemic potential.

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent ...

There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...

Jan. 18 (UPI) --Georgia officials on Friday halted all in-state poultry sales, and the U.S. Department of Health and Human Services awarded $590 million to Moderna to accelerate development of ...

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...

Jan 17 (Reuters) - The U.S. government has awarded Moderna (MRNA.O), opens new tab $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle ...